Document is current

Any future updates will be listed below

Efficacy of dostarlimab in recurrent or advanced mismatch Repair-Deficient endometrial Cancer as a Single-Agent therapy: A systematic review and Meta-Analysis

Crossref DOI link: https://doi.org/10.1007/s40199-025-00564-z

Published Online: 2025-07-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark